Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-04-09 @ 11:57 PM
Study NCT ID:
NCT00130520
Status:
COMPLETED
Last Update Posted:
2012-05-28
First Post:
2005-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer
Sponsor:
University of Arizona
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HSC #05-47;AVF3117s
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |